Fallon L - Search Results

1

Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6.

van Vollenhoven RF, Lee EB, Fallon L, Zwillich SH, Wilkinson B, Chapman D, DeMasi R, Keystone E. van Vollenhoven RF, et al. Among authors: fallon l. Arthritis Care Res (Hoboken). 2019 Jan;71(1):71-79. doi: 10.1002/acr.23585. Arthritis Care Res (Hoboken). 2019. PMID: 29696833 Free PMC article. Clinical Trial.

2

Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months.

Bykerk VP, Lee EB, van Vollenhoven R, Gruben DC, Fallon L, Woolcott JC, Keystone E. Bykerk VP, et al. Among authors: fallon l. Arthritis Care Res (Hoboken). 2022 Jan;74(1):131-141. doi: 10.1002/acr.24709. Arthritis Care Res (Hoboken). 2022. PMID: 34057820 Free PMC article. Clinical Trial.

3

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years.

Pope JE, Keystone E, Jamal S, Wang L, Fallon L, Woolcott J, Lazariciu I, Chapman D, Haraoui B. Pope JE, et al. Among authors: fallon l. ACR Open Rheumatol. 2019 Mar 28;1(2):73-82. doi: 10.1002/acr2.1010. eCollection 2019 Apr. ACR Open Rheumatol. 2019. PMID: 31777783 Free PMC article.

4

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib.

Coates LC, Bushmakin AG, FitzGerald O, Gladman DD, Fallon L, Cappelleri JC, Hsu MA, Helliwell PS. Coates LC, et al. Among authors: fallon l. Arthritis Res Ther. 2021 Mar 26;23(1):94. doi: 10.1186/s13075-021-02474-2. Arthritis Res Ther. 2021. PMID: 33766074 Free PMC article. Clinical Trial.

5

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo.

Gladman DD, Coates LC, Wu J, Fallon L, Bacci ED, Cappelleri JC, Bushmakin AG, Helliwell PS. Gladman DD, et al. Among authors: fallon l. Arthritis Res Ther. 2022 Feb 9;24(1):40. doi: 10.1186/s13075-022-02721-0. Arthritis Res Ther. 2022. PMID: 35139908 Free PMC article.

6

Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab.

van der Heijde D, Gladman DD, FitzGerald O, Kavanaugh A, Graham D, Wang C, Fallon L. van der Heijde D, et al. Among authors: fallon l. J Rheumatol. 2019 Sep;46(9):1089-1096. doi: 10.3899/jrheum.180971. Epub 2019 Mar 1. J Rheumatol. 2019. PMID: 30824647 Free article. Clinical Trial.

7

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.

Mease P, Charles-Schoeman C, Cohen S, Fallon L, Woolcott J, Yun H, Kremer J, Greenberg J, Malley W, Onofrei A, Kanik KS, Graham D, Wang C, Connell C, Valdez H, Hauben M, Hung E, Madsen A, Jones TV, Curtis JR. Mease P, et al. Among authors: fallon l. Ann Rheum Dis. 2020 Nov;79(11):1400-1413. doi: 10.1136/annrheumdis-2019-216761. Epub 2020 Aug 5. Ann Rheum Dis. 2020. PMID: 32759265 Free PMC article.

8

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib.

de Vlam K, Ogdie A, Bushmakin AG, Cappelleri JC, Fleischmann R, Taylor PC, Azevedo V, Fallon L, Woolcott J, Mease PJ. de Vlam K, et al. Among authors: fallon l. RMD Open. 2021 Jul;7(2):e001609. doi: 10.1136/rmdopen-2021-001609. RMD Open. 2021. PMID: 34226183 Free PMC article.

9

Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years.

Pope J, Bessette L, Jones N, Fallon L, Woolcott J, Gruben D, Crooks M, Gold D, Haraoui B. Pope J, et al. Among authors: fallon l. Rheumatology (Oxford). 2020 Mar 1;59(3):568-574. doi: 10.1093/rheumatology/kez324. Rheumatology (Oxford). 2020. PMID: 31410469

10

Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database.

Mease PJ, Young P, Gruben D, Fallon L, Germino R, Kavanaugh A. Mease PJ, et al. Among authors: fallon l. Adv Ther. 2022 Jun;39(6):2932-2945. doi: 10.1007/s12325-022-02084-7. Epub 2022 Apr 28. Adv Ther. 2022. PMID: 35482248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters